杜克·贝尔维尔特350与艾哈迈德·克莱尔帕特350研究 (DBACS):一个随机对照试验,在成年患者中进行,患有医疗阻断性玻璃眼瘤
Michael S Quist1, Andrew W Gross1, Nicholas A Johnson1
1Duke University Eye Center, Duke University, Durham, NC, USA.
Clinical ophthalmology (Auckland, N.Z.)
|September 24, 2025
概括
艾哈迈德ClearPath (ACP) 证明了优于Baerveldt 350 (BVT) 治疗青光眼的疗效,降低了眼内压力 (IOP). 在这项比较研究中,这两种设备都显示出可比的安全性.
科学领域:
- 眼科医生 眼科 眼科
- 视光眼管理 视光眼管理
- 手术设备 手术设备
背景情况:
- 青光眼排水装置 (GDD) 对于管理医疗耐火性青光眼至关重要.
- 没有门的GDD提供了一种手术选择,以降低眼内压力 (IOP).
- 对比不同GDD的疗效和安全性对于临床决策至关重要.
研究的目的:
- 为了比较两种无门的青光眼排水装置的疗效和安全性:Baerveldt 350 (BVT) 和Ahmed ClearPath 350 (ACP).
- 评估一年内眼内压力 (IOP) 降低,药物使用和并发症率.
主要方法:
- 一项随机对照试验,涉及76名患有医疗耐药性玻璃眼的患者.
- 患者被随机分配到接受BVT或ACP设备.
- 包括IOP,药物使用和并发症在内的结果在一年的随访期内进行了评估.
主要成果:
- 一年后,BVT和ACP群体都显示出显著的IOP减少.
- 与BVT组 (14.1 mmHg,-30.7%) 相比,ACP组的IOP平均值较低 (11.4 mmHg),并且比基线下降的百分比更大 (-44.1%).
- 两种设备的并发症率是罕见的,并且在两种设备之间是可比的,尽管这项研究的功率不足.
结论:
- 这两种非门型玻璃眼排水装置 (GDD) 都在一年内有效.
- 与Baerveldt 350 (BVT) 相比,Ahmed ClearPath (ACP) 在减少IOP方面表现出了统计学上显著的优势.
- 建议进行进一步的长期研究,以充分了解这些GDD之间的IOP降低差异.
相关概念视频
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K


